Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph H. Gleiter

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Pharmacology & Toxicology|November 8, 2002
Affinities of dihydrocodeine and its metabolites to opioid receptorsHelmut Schmidt, Stefan v Vormfelde, Klaus Klinder, et al.
Neurochemical Research|April 5, 2007
Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha releaseLusine Danielyan, Ali Lourhmati, Stephan Verleysdonk, et al.
British Journal of Clinical Pharmacology|December 21, 2002
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphineIngolf Meineke, Stefan Freudenthaler, Ute Hofmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 4, 2006
Role of renal nerves and salt intake on erythropoietin secretion in rats following carbon monoxide exposureCathérine Gebhard, Fotios Petroktistis, Hua Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Theophylline improves early allograft function in rat kidney transplantationAlmut Grenz, Detlef Baier, Fotios Petroktistis, et al.
Plos One|October 15, 2013
Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietinAli Lourhmati, Gayane H Buniatian, Christina Paul, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Analytica Chimica Acta|May 27, 2008
Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancerDino Bullinger, Holger Fröhlich, Fabian Klaus, et al.
BMC Cancer|April 7, 2009
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selectionCarsten Henneges, Dino Bullinger, Richard Fux, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical studyRichard Fux, Klaus Mörike, Anne M T Pröhmer, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Pharmacology & Toxicology|November 8, 2002
Affinities of dihydrocodeine and its metabolites to opioid receptorsHelmut Schmidt, Stefan v Vormfelde, Klaus Klinder, et al.
Neurochemical Research|April 5, 2007
Angiotensin receptor type 1 blockade in astroglia decreases hypoxia-induced cell damage and TNF alpha releaseLusine Danielyan, Ali Lourhmati, Stephan Verleysdonk, et al.
British Journal of Clinical Pharmacology|December 21, 2002
Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphineIngolf Meineke, Stefan Freudenthaler, Ute Hofmann, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 4, 2006
Role of renal nerves and salt intake on erythropoietin secretion in rats following carbon monoxide exposureCathérine Gebhard, Fotios Petroktistis, Hua Zhang, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 18, 2006
Theophylline improves early allograft function in rat kidney transplantationAlmut Grenz, Detlef Baier, Fotios Petroktistis, et al.
Plos One|October 15, 2013
Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietinAli Lourhmati, Gayane H Buniatian, Christina Paul, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Analytica Chimica Acta|May 27, 2008
Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancerDino Bullinger, Holger Fröhlich, Fabian Klaus, et al.
BMC Cancer|April 7, 2009
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selectionCarsten Henneges, Dino Bullinger, Richard Fux, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical studyRichard Fux, Klaus Mörike, Anne M T Pröhmer, et al.
Pageof 7